Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression.
10.3803/EnM.2015.30.3.343
- Author:
Seo Young SOHN
1
;
Ji Young JOUNG
;
Yoon Young CHO
;
Sun Mi PARK
;
Sang Man JIN
;
Jae Hoon CHUNG
;
Sun Wook KIM
Author Information
1. Center for Thyroid Cancer, National Cancer Center, Goyang, Korea.
- Publication Type:Original Article
- Keywords:
Thyroid neoplasms;
Body weight;
Thyroid hormones;
Thyrotropin
- MeSH:
Body Mass Index;
Body Weight;
Female;
Follow-Up Studies*;
Humans;
Iodine;
Male;
Retrospective Studies;
Thyroid Gland*;
Thyroid Hormones;
Thyroid Neoplasms*;
Thyroid Nodule;
Thyroidectomy;
Thyrotropin Alfa;
Thyrotropin*;
Thyroxine;
Weight Gain
- From:Endocrinology and Metabolism
2015;30(3):343-351
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: There are limited data about whether patients who receive initial treatment for differentiated thyroid cancer (DTC) gain or lose weight during long-term follow-up under thyroid stimulating hormone (TSH) suppression. This study was aimed to evaluate whether DTC patients under TSH suppression experience long-term weight gain after initial treatment. We also examined the impact of the radioactive iodine ablation therapy (RAIT) preparation method on changes of weight, comparing thyroid hormone withdrawal (THW) and recombinant human TSH (rhTSH). METHODS: We retrospectively reviewed 700 DTC patients who underwent a total thyroidectomy followed by either RAIT and levothyroxine (T4) replacement or T4 replacement alone. The control group included 350 age-matched patients with benign thyroid nodules followed during same period. Anthropometric data were measured at baseline, 1 to 2 years, and 3 to 4 years after thyroidectomy. Comparisons were made between weight and body mass index (BMI) at baseline and follow-up. RESULTS: Significant gains in weight and BMI were observed 3 to 4 years after initial treatment for female DTC but not in male patients. These gains among female DTC patients were also significant compared to age-matched control. Women in the THW group gained a significant amount of weight and BMI compared to baseline, while there was no increase in weight or BMI in the rhTSH group. There were no changes in weight and BMI in men according to RAIT preparation methods. CONCLUSION: Female DTC patients showed significant gains in weight and BMI during long-term follow-up after initial treatment. These changes were seen only in patients who underwent THW for RAIT.
